Magnetic Resonance Imaging Clinical Trial
Official title:
High-resolution MRI (7 Tesla) of Foraminal Stenosis and Differentiation of the Degenerated Discovertebral Unit - Comparison With 3 Tesla MRI
NCT number | NCT04441554 |
Other study ID # | R448 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | July 31, 2020 |
Est. completion date | December 1, 2023 |
Verified date | February 2023 |
Source | Balgrist University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
High-resolution MRI (7 Tesla) of the cervical spine is capable to differentiate osseous spurs from discus-material and better depict the compressed nerve in the neuroforamen compared to 3T MRI. Provide the surgeon with a detailed high-resolution anatomical image before surgery and potential no need for CT (if the bony anatomy is of crucial importance).
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 1, 2023 |
Est. primary completion date | November 30, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Informed consent as documented by signature (Appendix Informed Consent Form) - >18 years old - Patients with cervical back pain (radiculopathy) and scheduled surgery for foraminal stenosis or central stenosis or cervical periradicular injection therapy (PRT) Exclusion Criteria: - previous surgery - tumor patients - pregnancy or breast feeding - any MRI contra-indications |
Country | Name | City | State |
---|---|---|---|
Switzerland | Balgrist University Hospital | Zurich |
Lead Sponsor | Collaborator |
---|---|
Balgrist University Hospital |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | differentiation of compressed nerves in neuroforamen (7T vs 3T) | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03785171 -
Predicative Value of Multimodal MRI in Moyamoya Disease
|
||
Not yet recruiting |
NCT03726788 -
Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis
|
Phase 2 | |
Active, not recruiting |
NCT01956409 -
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
|
Phase 4 | |
Completed |
NCT01660841 -
Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
|
Phase 3 | |
Recruiting |
NCT03635619 -
The Application of 3T MRI in Esophageal Cancer
|
||
Recruiting |
NCT03658343 -
T2* MRI Analysis for Sarcoma
|
N/A | |
Recruiting |
NCT04555642 -
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI
|
||
Active, not recruiting |
NCT03441867 -
Neuroimaging Biomarker for Seizures
|
N/A | |
Recruiting |
NCT04850001 -
Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study
|
||
Not yet recruiting |
NCT05816213 -
Point-of-care Low-field MRI in Acute Stroke
|
||
Active, not recruiting |
NCT05498623 -
MR Fingerprinting for Diagnostic of Prostate Cancer
|
||
Recruiting |
NCT04996615 -
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women
|
||
Recruiting |
NCT04257747 -
Qualitative and Quantitative Evaluation of Vascular Flows of Radial, Ulnar and Interdigital Arterial Trees Under Normal and Pathological Conditions by 3 Tesla MRI
|
N/A | |
Recruiting |
NCT05889117 -
Brain Stimulation for Concussion
|
N/A | |
Completed |
NCT02540967 -
Drug Use Investigation of Gadovist.
|
||
Completed |
NCT05103189 -
4D-flow Cardiac MRI to Assess Pulmonary Arterial Pressure in Pulmonary Hypertension
|
N/A | |
Completed |
NCT02567318 -
Is the Volume of the Caudate Nuclei Associated With Area of Secondary Hyperalgesia?
|
N/A | |
Recruiting |
NCT02834585 -
Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)
|
N/A | |
Active, not recruiting |
NCT02446665 -
Disease Status in Primary Sclerosing Cholangitis by Elastography
|
N/A | |
Completed |
NCT01721785 -
Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer
|
N/A |